A spontaneously immortalized Schwann cell line from aldose reductase-deficient mice as a useful tool for studying polyol pathway and aldehyde metabolism
Open Access
- 1 March 2018
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 144 (6), 710-722
- https://doi.org/10.1111/jnc.14277
Abstract
The increased glucose flux into the polyol pathway via aldose reductase (AR) is recognized as a major contributing factor for the pathogenesis of diabetic neuropathy, whereas little is known about the functional significance of AR in the peripheral nervous system. Spontaneously immortalized Schwann cell lines established from long-term cultures of AR-deficient and normal C57BL/6 mouse dorsal root ganglia and peripheral nerves can be useful tools for studying the physiological and pathological roles of AR. These cell lines, designated as immortalized knockout AR Schwann cells 1 (IKARS1) and 1970C3, respectively, demonstrated distinctive Schwann cell phenotypes, such as spindle-shaped morphology and immunoreactivity to S100, p75 neurotrophin receptor, and vimentin, and extracellular release of neurotrophic factors. Conditioned media obtained from these cells promoted neuronal survival and neurite outgrowth of cultured adult mouse dorsal root ganglia neurons. Microarray and real-time RT-PCR analyses revealed significantly down-regulated mRNA expression of polyol pathway-related enzymes, sorbitol dehydrogenase and ketohexokinase, in IKARS1 cells compared with those in 1970C3 cells. In contrast, significantly up-regulated mRNA expression of aldo-keto reductases (AKR1B7 and AKR1B8) and aldehyde dehydrogenases (ALDH1L2, ALDH5A1, and ALDH7A1) was detected in IKARS1 cells compared with 1970C3 cells. Exposure to reactive aldehydes (3-deoxyglucosone, methylglyoxal, and 4-hydroxynonenal) significantly up-regulated the mRNA expression of AKR1B7 and AKR1B8 in IKARS1 cells, but not in 1970C3 cells. Because no significant differences in viability between these two cell lines after exposure to these aldehydes were observed, it can be assumed that the aldehyde detoxification is taken over by AKR1B7 and AKR1B8 in the absence of AR.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology, Japan (16K07048)
- Nukada Institute for Medical and Biological Research, Chiba, Japan
- Medical Institute of Bioregulation, Kyushu University
- Sumitomo Dainippon Pharma Co., Ltd.
This publication has 45 references indexed in Scilit:
- A Small Peptide with Therapeutic Potential for Inflammatory Acne VulgarisPLOS ONE, 2013
- Deletion of Aldose Reductase from Mice Inhibits Diabetes-Induced Retinal Capillary Degeneration and Superoxide GenerationPLOS ONE, 2013
- GDNF promotes neurite outgrowth and upregulates galectin-1 through the RET/PI3K signaling in cultured adult rat dorsal root ganglion neuronsNeurochemistry International, 2013
- Long‐term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathyDiabetic Medicine, 2012
- Aldose Reductase, Oxidative Stress, and Diabetic MellitusFrontiers in Pharmacology, 2012
- Aldo-Keto Reductases 1B in Endocrinology and MetabolismFrontiers in Pharmacology, 2012
- Functional expression of novel human and murine AKR1B genesChemico-Biological Interactions, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLoS Biology, 2010
- Neuroprotective properties of ciliary neurotrophic factor for cultured adult rat dorsal root ganglion neuronsHistochemistry and Cell Biology, 2008
- Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCRBiological Procedures Online, 2006